Bank of America’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.5M Sell
8,682,907
-2,838,753
-25% -$11.6M ﹤0.01% 2021
2025
Q4
$38.8M Sell
11,521,660
-173,884
-1% -$452K ﹤0.01% 1733
2025
Q3
$15.3M Buy
11,695,544
+8,337,672
+248% +$8.63M ﹤0.01% 2861
2025
Q2
$2.41M Buy
3,357,872
+1,929,356
+135% +$1.51M ﹤0.01% 4612
2025
Q1
$2.1M Buy
1,428,516
+750,371
+111% +$1.79M ﹤0.01% 4641
2024
Q4
$3M Buy
678,145
+258,372
+62% +$1.05M ﹤0.01% 4084
2024
Q3
$1.73M Sell
419,773
-292,614
-41% -$1.57M ﹤0.01% 4666
2024
Q2
$4.64M Sell
712,387
-193,902
-21% -$1.37M ﹤0.01% 3681
2024
Q1
$7.89M Buy
906,289
+219,523
+32% +$2.66M ﹤0.01% 3204
2023
Q4
$7.86M Sell
686,766
-110,860
-14% -$1.1M ﹤0.01% 3142
2023
Q3
$7.68M Buy
797,626
+60,348
+8% +$591K ﹤0.01% 2993
2023
Q2
$7.84M Sell
737,278
-318,831
-30% -$3.43M ﹤0.01% 2956
2023
Q1
$11.1M Buy
1,056,109
+122,998
+13% +$1.38M ﹤0.01% 2719
2022
Q4
$11.6M Buy
933,111
+283,011
+44% +$3.21M ﹤0.01% 2541
2022
Q3
$6.73M Buy
650,100
+255,130
+65% +$2.89M ﹤0.01% 3028
2022
Q2
$4.55M Sell
394,970
-204,364
-34% -$2.41M ﹤0.01% 3503
2022
Q1
$7.54M Sell
599,334
-20,046
-3% -$230K ﹤0.01% 3168
2021
Q4
$7.22M Buy
619,380
+216,160
+54% +$2.65M ﹤0.01% 3281
2021
Q3
$5.26M Buy
403,220
+16,822
+4% +$217K ﹤0.01% 3512
2021
Q2
$4.97M Sell
386,398
-33,150
-8% -$379K ﹤0.01% 3506
2021
Q1
$4.69M Buy
419,548
+174,020
+71% +$1.84M ﹤0.01% 3462
2020
Q4
$2.8M Sell
245,528
-117,648
-32% -$1.29M ﹤0.01% 3650
2020
Q3
$3.27M Sell
363,176
-198,413
-35% -$1.97M ﹤0.01% 3294
2020
Q2
$5.79M Buy
561,589
+244,812
+77% +$2.51M ﹤0.01% 2711
2020
Q1
$3.2M Sell
316,777
-87,008
-22% -$1.02M ﹤0.01% 3096
2019
Q4
$5.38M Sell
403,785
-336,087
-45% -$3.71M ﹤0.01% 3172
2019
Q3
$6.35M Buy
739,872
+162,948
+28% +$1.58M ﹤0.01% 2972
2019
Q2
$6.31M Buy
576,924
+279,310
+94% +$3.13M ﹤0.01% 3009
2019
Q1
$3.37M Buy
297,614
+115,795
+64% +$1.29M ﹤0.01% 3543
2018
Q4
$1.58M Buy
181,819
+88,396
+95% +$1.01M ﹤0.01% 4035
2018
Q3
$1.45M Sell
93,423
-142,283
-60% -$2.25M ﹤0.01% 4223
2018
Q2
$3.77M Sell
235,706
-19,488
-8% -$288K ﹤0.01% 3423
2018
Q1
$3.3M Sell
255,194
-46,341
-15% -$578K ﹤0.01% 3457
2017
Q4
$3.79M Buy
301,535
+5,384
+2% +$70.3K ﹤0.01% 3379
2017
Q3
$3.91M Buy
296,151
+86,334
+41% +$1.19M ﹤0.01% 3401
2017
Q2
$3.32M Buy
209,817
+19,273
+10% +$280K ﹤0.01% 3425
2017
Q1
$2.72M Buy
190,544
+128,384
+207% +$1.76M ﹤0.01% 3593
2016
Q4
$796K Sell
62,160
-140,586
-69% -$1.78M ﹤0.01% 4498
2016
Q3
$2.7M Buy
202,746
+86,212
+74% +$1.01M ﹤0.01% 3395
2016
Q2
$1.28M Sell
116,534
-35,443
-23% -$346K ﹤0.01% 3983
2016
Q1
$1.39M Sell
151,977
-76,627
-34% -$632K ﹤0.01% 3874
2015
Q4
$2.22M Sell
228,604
-2,175
-0.9% -$21K ﹤0.01% 3709
2015
Q3
$2.01M Sell
230,779
-51,393
-18% -$480K ﹤0.01% 3764
2015
Q2
$2.85M Buy
282,172
+264,640
+1,509% +$3.08M ﹤0.01% 3121
2015
Q1
$235K Buy
17,532
+110
+0.6% +$1.44K ﹤0.01% 4827
2014
Q4
$224K Buy
17,422
+1,720
+11% +$19.7K ﹤0.01% 5283
2014
Q3
$170K Sell
15,702
-10,100
-39% -$116K ﹤0.01% 5530
2014
Q2
$332K Sell
25,802
-24,014
-48% -$261K ﹤0.01% 5025
2014
Q1
$513K Sell
49,816
-12,747
-20% -$143K ﹤0.01% 4560
2013
Q4
$608K Buy
62,563
+11,727
+23% +$105K ﹤0.01% 4586
2013
Q3
$504K Sell
50,836
-21,735
-30% -$213K ﹤0.01% 4632
2013
Q2
$604K Buy
+72,571
New +$880K ﹤0.01% 4565

Other funds holding IRWD

Bank of America's IRWD Position: Q1 2026 in Review

Bank of America reduced its Ironwood Pharmaceuticals (IRWD) stake by 25% in Q1 2026, selling an estimated $11.6M and leaving 8,682,907 shares worth $30.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2021.

Bank of America first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.8M in Q4 2025. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Bank of America held 8,682,907 shares of Ironwood Pharmaceuticals worth $30.5M as of Q1 2026.
  • Bank of America sold 2,838,753 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $11.6M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2021 holding.
  • Bank of America first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Ironwood Pharmaceuticals position peaked at $38.8M in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.